Journal article
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
- Abstract:
- BACKGROUND: Lumefantrine and atovaquone are highly lipophilic anti-malarial drugs. As a consequence absorption is increased when the drugs are taken together with a fatty meal, but the free fraction of active drug decreases in the presence of triglyceride-rich plasma lipoproteins. In this study, the consequences of lipidaemia on anti-malarial drug efficacy were assessed in vitro. METHODS: Serum was obtained from non-immune volunteers under fasting conditions and after ingestion of a high fat meal and used in standard Plasmodium falciparum in-vitro susceptibility assays. Anti-malarial drugs, including lumefantrine, atovaquone and chloroquine in five-fold dilutions (range 0.05 ng/ml-1 ug/mL) were diluted in culture medium supplemented with fasting or post-prandial 10% donor serum. The in-vitro drug susceptibility of parasite isolates was determined using the ³H-hypoxanthine uptake inhibition method and expressed as the concentration which gave 50% inhibition of hypoxanthine uptake (IC₅₀). RESULTS: Doubling plasma triglyceride concentrations (from 160 mg/dL to 320 mg/dL), resulted in an approximate doubling of the IC₅₀ for lumefantrine (191 ng/mL to 465 ng/mL, P < 0.01) and a 20-fold increase in the IC₅₀ for atovaquone (0.5 ng/mL to 12 ng/ml; P < 0.01). In contrast, susceptibility to the hydrophilic anti-malarial chloroquine did not change in relation to triglyceride content of the medium. CONCLUSIONS: Lipidaemia reduces the anti-malarial activity of lipophilic anti-malarial drugs. This is an important confounder in laboratory in vitro testing and it could have therapeutic relevance.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 247.6KB, Terms of use)
-
- Publisher copy:
- 10.1186/1475-2875-11-177
Authors
- Publisher:
- BioMed Central
- Journal:
- Malaria journal More from this journal
- Volume:
- 11
- Issue:
- 1
- Article number:
- 177
- Publication date:
- 2012-01-01
- DOI:
- EISSN:
-
1475-2875
- ISSN:
-
1475-2875
- Language:
-
English
- Keywords:
- Pubs id:
-
334766
- UUID:
-
uuid:ef452625-83a5-4271-908d-985f8fc17967
- Local pid:
-
pubs:334766
- Source identifiers:
-
334766
- Deposit date:
-
2013-11-16
- ARK identifier:
Terms of use
- Copyright holder:
- Chotivanich et al
- Copyright date:
- 2012
- Notes:
- © 2012 Chotivanich et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record